Article: Aldara (Imiquimod) Cream, 5% Included in Multiple Poster Presentations at American Academy of Dermatology's ACADEMY 06 Meeting.

ST. PAUL, Minn. -- Aldara is First and Only Immune Response Modifier Indicated for the Treatment of Actinic Keratosis, Superficial Basal Cell Carcinoma and External Genital and Perianal Warts

3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology's (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external genital and perianal warts. The prescription therapy works by stimulating the skin's immune response to clear ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!